BMUC retweeted
Beautiful summary of key findings & impact of @SFreedlandMD's #EMBARKTrial from @BertrandTOMBAL @bmuc_be #BMUC2024
And clear case for careful distinction of "Low risk" vs "High risk" #BCR
Key factors (for HR):
•GG4 or 5
•PSADT <1yr
•Time to relapse <18m
@KU_Leuven @UZLeuven
BMUC retweeted
Excited to unveil the biological landscape of penile cancer at @ASCO #GU24. Stop by poster board E7 for a journey into the penile cancer single-cell RNA sequencing wonderland 🧬🔬
Big shoutout to @MaartenAlbersen for all the guidance 🙏🏼
BMUC retweeted
Great to have attended the #BMUC23 conference! 🔬📊
The perspective 👀 from each specialty was truly insightful
Kudos 👏 to the team for putting together an excellent event!
#BMUC23 #urology #conference – at Kortrijk, België
All uro-onco topics covered at #BMUC23: testis, penile, bladder and prostate cancer with @Alex_Papachris @jbbeauval @SiskaVB @EveraertsW @devos_gaetan @ThRoumeguere @NMartinezChanza @karolien_goffin @piet_ost and many more! Join us on the 24 and 25/03: bmuc.be/bmuc2023/
BMUC retweeted
Radiotherapy for Penile cancer is now supported by the @Uroweb guidelines! @VedangMurthy as the expert on stage! Amazing knowledge dissemination! Dose and field are important in adjuvant CRT. #BMUC23
BMUC retweeted
Beautiful opening #BMUC23
Outside: a rainbow 🌈
Inside: Urologist is the orchestra chief in #mCRPC among all other specialties 🎶
@LumenNicolaas @bmuc_be @sb_uro @BVUrologie @Uroweb
BMUC retweeted
🇧🇪 First day, the 10th edition of the BMUC meeting, with many friends !
@piet_ost Thanks for the invitation in #Bruxelles
🙏.
@VedangMurthy
@jbbeauval
@ThRoumeguere
@BertrandTOMBAL – at La Hulpe, Belgique
BMUC retweeted
Nice poster @ASCO #GU23 from @weeloonong @AmarUKishan and MARCAP consortium on testosterone recovery post ☢️#radiotherapy and 💉ADT in prostate cancer… can take quite some time!!! 3mo ADT = 6 mo to recover, 6mo ADT = 12mo to recover. @OncoAlert #pcsm @TROGfightcancer
BMUC retweeted
#GU23 very practical data to help inform patients on probability of testosterone recovery, time to recovery, based on ADT duration and baseline levels #pcsm @OncoAlert
BMUC retweeted
yes, PSMA PET before sRT is included in the Primordium study. Please support this trial testing if 6mo Apa improves ppMFS clinicaltrials.gov/ct2/show/…
BMUC retweeted
🔥🔥 primary endpoint analysis from @nickva1 of PACE-A; SBRT versus robotic prostatectomy for #prostatecancer RCT. Co-primary toxicity endpoints (continence/bowel) #GU23 @ASCO @OncoAlert @NHSuk. N=123, SBRT had ⬇️ pad use ⬇️ sexual dysfunction but ⬆️ bowel bother. All low grade.
BMUC retweeted
4/ #VIOLET: Terbium-161 PSMA-I&T. Can auger emitter therapy work? Will it target small volume disease better?
⏱Dose cohort 3 (7.4 GBq) being scheduled...
@ButeauJames @LouiseKostos @pj_physics @AzadOncology Thanks @Isotopia_il @PCF_Science
RIP JV bmj.com/content/371/bmj.m480…
BMUC retweeted
Joe O’Sullivan presents CHHiP trial update 10-year data confirms 60/20 hypofractionated #radiotherapy as the standard of care for #prostatecancer (mostly intermediate). Good to see late significant GI/GU toxicity <1-2% at 10 years! @asco #GU23 #radonc #pcsm @OncoAlert
Looking forward to hosting our (inter)national speakers for the BMUC23 conference on multiD management in uro-oncology with @PaulSargos @VedangMurthy and more! Register here: bmuc.be/bmuc2023/
This Post is from an account that no longer exists. Learn more
All uro-onco topics covered at #BMUC23: testis, penile, bladder and prostate cancer with @Alex_Papachris @jbbeauval @SiskaVB @EveraertsW @devos_gaetan @ThRoumeguere @NMartinezChanza @karolien_goffin @piet_ost and many more! Join us on the 24 and 25/03: bmuc.be/bmuc2023/
BMUC retweeted
We may be small 🇧🇪 but we can take on our neighbors in 🇪🇺!
Register now for EBU In-Service Assessment 2023!
If you dare! 😏👇
examinations.ebu.com/examina…
@UrowebESU @ESRUrology @UrologieEeklo @AalstOlv @UrologieBrugge @sb_uro @BVUrologie @bmuc_be @EBU_Urology
#urology #exam – at Louvain, Belgium
This Post is from an account that no longer exists. Learn more
